By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Omni Bio Pharmaceutical 

700 17th Street
Suite 1200
Denver  Colorado  80202  U.S.A.
Phone: 303-893-1003 Fax: n/a


SEARCH JOBS








Company News
Omni Bio Pharmaceutical Announces Encouraging Clinical Data For Use Of Alpha-1 Antitrypsin (AAT) In Steroid-Resistant Graft Versus Host Disease 12/10/2014 11:47:28 AM
Omni Bio Pharmaceutical Successfully Completes Cell Line Optimization For Novel Recombinant Biologic 11/20/2014 2:47:38 PM
Omni Bio Pharmaceutical Announces Presentation Of Phase 1/2 Clinical Data For AAT At American Heart Association Scientific Sessions 11/20/2014 11:43:42 AM
Omni Bio Pharmaceutical Announces Phase 1/2 Clinical Data Of AAT In Myocardial Infarction At American Heart Association Scientific Session 11/19/2014 11:07:30 AM
Omni Bio Pharmaceutical Successfully Completes Cell Line Optimization For Novel Recombinant Biologic 11/18/2014 3:19:29 PM
Omni Bio Pharmaceutical To Present At 7th Annual BioPharm America Conference 9/18/2014 1:59:01 PM
Omni Bio Pharmaceutical Appoints Jack Riccardi As Chief Financial Officer 8/14/2014 1:32:10 PM
Omni Bio Pharmaceutical Announces Grant Of New Use Patent In Europe 5/8/2014 8:53:44 AM
Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest To Chief Development Officer Role 5/1/2014 10:00:15 AM
Omni Bio Pharmaceutical Announces Publication Of Its Pilot Study Of Alpha-1 Antitrypsin In Type 1 Diabetes 4/30/2014 11:11:50 AM
12345
//-->